Jessica Maa has extensive work experience in the field of Quality Assurance. Jessica started their career at Maxim Biomedical, Inc. as a Quality Assurance Specialist in 2012 and was later promoted to the role of Quality Assurance Manager in 2016. In these positions, Jessica facilitated the functions of the Quality Assurance department and provided daily support to manufacturing, inventory, and quality control departments. Jessica played a significant role in ensuring the effectiveness and compliance of the Quality System to ISO13485 and FDA 21 CFR Part 820. Jessica also led the implementation of Quality Management Systems, including NCR/CAPA, Internal/External Audits, Document Control, Supplier Quality, and Complaint Handling.
Before joining Maxim Biomedical, Inc., Jessica participated in the Undergraduate Technology Apprenticeship Program at the University of Maryland from 2010 to 2011.
Jessica Maa received their Bachelor of Arts (B.A.) degree in Fine/Studio Arts, General from the University of Maryland in 2012. In 2011, they also briefly studied at Yonsei University. Jessica obtained certifications in ISO 13485:2003 Quality Management Standard for Medical Devices in April 2013 and FDA cGMP for Medical Device Training 21CFR820 in November 2012.
Current role
Chief Compliance Officer & Fund Counsel & Managing Director at Kennedy Lewis Investment Management
General Counsel & Chief Compliance Officer at PlanSource
Chief Financial Officer & Chief Compliance Officer at Prelude Growth Partners
Chief Compliance Officer, First Eagle Alternative Credit, LLC & First Eagle Private Credit Fund at First Eagle Investments
Chief Compliance Officer at Paxful
Access the worlds's biggest network of public org charts
Learn more